Expedia Group, Inc. (EXPE) is an online travel company operating brands including Expedia, Hotels.com, and Vrbo. The central target used here is the arithmetic mean of roughly 18 recent, verifiable analyst price targets from named firms, which averages about $337 and rounds to $340. The low-to-high range is wide: Morgan Stanley set the lowest target at $235 (an Underweight/Sell view dated September 2026), while Evercore ISI carries the highest at $430. That spread — nearly $200, or almost 70% of the current share price — signals that analysts are far from unified.
Bullish firms cluster in the upper $300s to low $400s. BTIG ($400), Wedbush ($417), Evercore ISI ($430), B. Riley ($390), and Benchmark ($360) all maintain Buy ratings, citing strong execution, B2B growth, and raised guidance. A large neutral block — Bernstein ($310), J.P. Morgan ($330), Piper Sandler ($325), UBS ($351), and Rosenblatt ($360) — sits near the current price, reflecting a view that positives are largely priced in. At the cautious end, Wells Fargo cut its target to $275 in early October and Truist to $288, while Morgan Stanley downgraded the stock to Sell, noting platform consolidation and cost discipline but flagging weak consumer-facing differentiation.
Expedia closed at $285.64 on October 21, 2026, down 5.03% on the day, leaving it below the $300 level and its 52-week high of $342.00. Reaching $340 would require a gain of about 19%, a substantial move rather than an incremental one. The market capitalization is roughly $34.3 billion, and the stock trades at a trailing P/E (price-to-earnings ratio) of about 17.8, with a modest 0.64% dividend yield.
The path toward the target likely hinges on earnings execution. Expedia raised its full-year 2026 outlook after a strong second quarter in which gross bookings grew 12%, revenue rose 14%, and adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) increased 23% to $1.12 billion. Continued beats on bookings and margins, combined with a stabilization of travel demand, could support re-rating toward the higher end of the analyst range.
Several factors support a higher valuation. Expedia has delivered five consecutive quarters above the top of its revenue and profit guidance. B2B gross bookings have compounded at a roughly 20%-plus pace, and B2C margins have improved through marketing efficiency and cost discipline. The company raised its 2026 revenue guidance to roughly $16.05 billion to $16.22 billion and lifted its full-year adjusted EBITDA margin expansion outlook to 150–175 basis points. Management also cited its fastest U.S. consumer booking growth in 15 quarters, suggesting resilient underlying demand.
Valuation also leaves room: at a mid-teens forward P/E relative to double-digit projected EPS (earnings per share) growth, the stock is not priced for perfection. Continued analyst target increases — UBS, BTIG, Wedbush, and B. Riley all raised targets after Q2 — could further anchor sentiment.
The principal risk is structural: the rise of AI travel agents, including Meta Platforms' (META) Muse agent, has raised concerns that generative AI could disintermediate online travel agencies and compress their economics. Wells Fargo explicitly cited "renewed agentic concerns" when cutting its target. Competitive pressure from rivals such as Airbnb (ABNB) and Booking Holdings (BKNG) remains intense.
Softer fundamentals also matter. Wells Fargo expects Q3 2026 to be the low point for room-night growth, with three consecutive quarters of decelerating gross bookings growth and choppy U.S. average daily rates. A slower Europe and tough second-half comparisons add to the caution. If travel demand softens or marketing costs rise, margin expansion could stall and derail the move toward $340.
The $342 area, the 52-week high, is the most important resistance level and sits just above the $340 target. A decisive break above it would mark a new high and signal stronger momentum. The recent October 21 session tested an intraday low near $283, establishing that zone as near-term support. The psychological $300 level, where the stock traded just before its October decline, is a secondary pivot. Below that, the stock's broader base sits far lower, near the 52-week low of $185.34.
Analyst price targets typically reflect a research horizon of about 12 months, and most of the targets used here were published from August through October 2026. Investors should watch the Q3 2026 earnings report scheduled for November 4, 2026, along with guidance on Q4 gross bookings and 2027 expectations. Revisions from cautious firms such as Morgan Stanley and Wells Fargo, U.S. travel-demand data, and any developments around AI travel agents will be pivotal. Rate decisions and macroeconomic data that shape discretionary travel spending also bear watching.
For traders seeking an objective, data-driven complement to analyst research, AI Daily Buy/Sell Signals from Tickeron uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on evolving market conditions, technical behavior, and AI-driven analysis. The tool can help investors discover opportunities, monitor existing positions, and identify changing trends more efficiently than manual screening. Consider reviewing Tickeron's AI Daily Buy/Sell Signals as part of a broader due-diligence routine.
The $340 target is a mathematical average of analyst price targets, not a forecast, and it sits roughly 19% above the latest price of $285.64. The wide $235-to-$430 range reflects a genuine split between analysts who see AI disruption and decelerating bookings as dominant risks and those who emphasize B2B momentum, margin gains, and raised guidance. Reaching $340 would require clearing the 52-week high near $342 and sustaining strong bookings and profitability, while fending off AI and competitive threats. The most important near-term catalysts are the November earnings report and any shift in cautious analyst positioning.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, EXPE has been closely correlated with BKNG. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if EXPE jumps, then BKNG could also see price increases.
| Ticker / NAME | Correlation To EXPE | 1D Price Change % | ||
|---|---|---|---|---|
| EXPE | 100% | -3.18% | ||
| BKNG - EXPE | 74% Closely correlated | -3.27% | ||
| ABNB - EXPE | 53% Loosely correlated | -2.13% | ||
| MMYT - EXPE | 49% Loosely correlated | -7.17% | ||
| TNL - EXPE | 45% Loosely correlated | -3.55% | ||
| TRIP - EXPE | 45% Loosely correlated | -2.69% | ||
More | ||||
| Ticker / NAME | Correlation To EXPE | 1D Price Change % |
|---|---|---|
| EXPE | 100% | -3.18% |
| EXPE (2 stocks) | 97% Closely correlated | -3.22% |
| Consumer Sundries (18 stocks) | 80% Closely correlated | -2.00% |
| Consumer Non Durables (182 stocks) | 2% Poorly correlated | -1.59% |